Search

Your search keyword '"Canonica, Giorgio Walter"' showing total 1,728 results

Search Constraints

Start Over You searched for: Author "Canonica, Giorgio Walter" Remove constraint Author: "Canonica, Giorgio Walter"
1,728 results on '"Canonica, Giorgio Walter"'

Search Results

2. Exploring Definitions and Predictors of Response to Biologics for Severe Asthma

3. International Variation in Severe Exacerbation Rates in Patients With Severe Asthma

10. Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study

12. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

14. Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry

16. Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus

18. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry

22. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

26. Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps

30. WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates inCOVID-19

31. Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life

32. ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study

35. Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review.

36. SANI Clinical Remission definition: a useful tool in Severe Asthma management.

37. WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates inCOVID-19

38. WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways

39. Exploring the Potential Role of Metabolomics in COPD: A Concise Review

41. Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study

42. Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”

43. Defining a Severe Asthma Super-Responder: Findings from a Delphi Process

44. Severe asthma: One disease and multiple definitions

45. Airways Type-2 Related Disorders: Multiorgan, Systemic or Syndemic Disease?

50. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Catalog

Books, media, physical & digital resources